L
lacanumab
Productby Eisai and Biogen
Heard in 2 episodes across 2 shows since Aug 2026
Lecanemab is an anti-amyloid monoclonal antibody used to treat early Alzheimer’s disease by targeting amyloid-beta plaques; it was developed by Eisai and Biogen and marketed as Leqembi.
Episodes
2
across 2 shows
First heard
Aug 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 1 |
| Sep 2026 | 1 |
| Oct 2026 | 0 |
Episodes
2 episodes featuring lacanumab, newest first
